Evidence map›Paper›PMID 42352068›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Wei-Sheng Wen, Hsin-Lin Cheng, Zheng-Qi He, Ming-Wei Lee, Yu-Xuan Wu, Tzu-Huan Hung, Shang-Ting Tsai, Po-Hui Wang, Jiann-Jou Yang

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei-Sheng WenInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Hsin-Lin ChengDepartment of Biomedical Sciences, Chung Shan Medical University, Taichung 40201, Taiwan.
Zheng-Qi HeDepartment of Biomedical Sciences, Chung Shan Medical University, Taichung 40201, Taiwan.
Ming-Wei LeeDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Yu-Xuan WuInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Tzu-Huan HungCrop Genetic Resources and Biotechnology Division, Taiwan Agricultural Research Institute, Taichung 413008, Taiwan.ORCID 0000-0001-5884-2778
Shang-Ting TsaiDepartment of Applied Chemistry, National Chiayi University, Chiayi City 600355, Taiwan.ORCID 0000-0001-5705-602X
Po-Hui WangInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Jiann-Jou YangDepartment of Biomedical Sciences, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0002-9019-2178

Funding

National Science and Technology Council NSTC 113-2320-B-040-011-MY3
6 · The paper itself

Abstract

Cisplatin is a widely used platinum-based chemotherapeutic agent that often causes irreversible hair cell loss, leading to hearing impairment. To date, effective strategies for preventing cisplatin-induced ototoxicity remain limited.

Indexed as

antioxidantcisplatinCorchorus olitorius L.hair cellROStransgenic zebrafish

Identifiers

PMID42352068
PMCPMC13295814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.